Gravis G, Marino P, Olive D, Penault-LLorca F, et al. A non-inferiority randomized phase III trial of standard immunotherapy by checkpoint inhibitors vs. reduced dose intensity in responding patients with metastatic cancer: the MOIO protocol study. BMC Cancer 2023;23:393.
PMID: 37131154